NovoCure Limited (NVCR)
18.88
-0.09 (-0.47%)
At close: Mar 28, 2025, 3:59 PM
18.77
-0.58%
After-hours: Mar 28, 2025, 07:47 PM EDT
NovoCure Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | -168.63M | -207.04M | -92.53M | -58.35M | 19.81M | -7.23M | -63.56M | -61.66M | -131.84M | -111.58M | -80.68M | -77.37M |
| Depreciation & Amortization | -14.41M | 10.97M | 10.62M | 10.25M | 9.15M | 8.46M | 9.01M | 7.68M | 5.65M | 3.15M | 1.96M | 1.22M |
| Stock-Based Compensation | 160.03M | 115.61M | 106.95M | 94.9M | 75.72M | 52.42M | 39.85M | 27.12M | 22.14M | 11.86M | 4.62M | 5.12M |
| Other Working Capital | n/a | -5.8M | -666K | -6.46M | -702K | -3.56M | 6.59M | 14.1M | 7.25M | 133K | 720K | 20K |
| Other Non-Cash Items | -3.37M | -22.43M | -6.05M | 3.01M | 3.26M | -2.17M | 1.02M | 252K | 155K | 1M | -19K | 11.5M |
| Deferred Income Tax | n/a | n/a | n/a | 3.88M | -270K | -519K | 407K | 241K | 5.75M | 46K | 23K | 19K |
| Change in Working Capital | n/a | 29.56M | 11.8M | 29.07M | -8.52M | -24.33M | 11.41M | -6.76M | -9.44M | -4.36M | -152K | 6.8M |
| Operating Cash Flow | -26.37M | -73.34M | 30.79M | 82.76M | 99.15M | 26.62M | -1.86M | -33.13M | -107.59M | -99.88M | -74.24M | -52.72M |
| Capital Expenditures | -42.85M | -27.09M | -21.36M | -24.17M | -14.97M | -10.48M | -6.71M | -7.37M | -17.66M | -10.27M | -2.32M | -3.63M |
| Acquisitions | n/a | n/a | 118.6M | 120.66M | 457.88M | 41.18M | 3.79M | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -875.39M | -1B | -1.3B | -1.08B | -607.88M | -461.84M | -253.78M | -104.01M | -239.34M | -209M | -137.98M | n/a |
| Sales Maturities Of Investments | 778M | 1.21B | 1.18B | 958M | 150M | 420.66M | 255M | 120M | 270M | 104M | 93M | 15.05M |
| Other Investing Acitivies | n/a | n/a | -118.6M | -120.66M | -457.88M | -41.18M | -3.79M | -1.86M | -180K | -26K | 1.12M | -1.02M |
| Investing Cash Flow | -140.24M | 184.15M | -139.96M | -144.83M | -472.85M | -51.67M | -5.49M | 6.77M | 12.81M | -115.3M | -46.18M | 10.4M |
| Debt Repayment | 84.01M | -10K | -28K | -26K | 408.41M | -31K | 49.07M | -57K | 72.82M | 22.82M | -9K | -8.42M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5K | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 2.16M | 11.38M | 10.29M | 21.18M | 28.43M | 59.24M | 18.47M | 3.69M | 1.69M | 2.04M | 2.15M | 2K |
| Financial Cash Flow | 90.31M | 15.79M | 15.49M | 25.7M | 440.21M | 61.68M | 69.37M | 5.17M | 75.12M | 276.99M | 2.15M | 183.32M |
| Net Cash Flow | -76.47M | 126.73M | -93.78M | -36.56M | 66.76M | 36.66M | 62.04M | -21.19M | -19.64M | 61.81M | -118.28M | 141M |
| Free Cash Flow | -69.22M | -100.43M | 9.43M | 58.59M | 84.18M | 16.14M | -8.58M | -40.5M | -125.26M | -110.16M | -76.56M | -56.34M |